The sun cut across Skyline Heights, too bright for a man who'd only fallen asleep a few hours earlier. Kael rolled over, groaning—until a glowing window appeared above him.
[Reward Unlocked: Future Card (1-Time Use)]
He squinted. "...What now?"
[Today is May 1st. Labor Day. To celebrate human perseverance, the system has granted you a reward.]
Kael stared at the text with a dead expression. "…You're giving me presents because it's Labor Day? What are you, a union rep?"
Still, he tapped.
[Future Card: Glimpse one possible outcome within 15 days. Accuracy not guaranteed. Choose focus:
[Business]
[Relationship]
[Health]
He rubbed his temples. "Health? I'd rather not see myself in a hospital bed. Relationship? …There's nothing to see. Business it is."
The interface pulsed.
[Aeterna Biocore ]
[ChronoCell: Regenerative therapy candidate. Estimated stock surge: +500%]
Kael leaned forward, suddenly awake.
"ChronoCell…?"
The system spilled more data:
Type: Regenerative drug targeting cellular degeneration
Method: Nanoparticle-assisted cell repair & mitochondrial enhancement
Patients: Early-stage Parkinson's showed significant motor recovery after 90 days
Unofficial Nickname:The Reset Pill (coined by patients online)
Kael muttered under his breath, "A pill that resets the body… sounds like science fiction. But the numbers…"
His mind flashed back to the Warren Buffett case study. $1,000 in Berkshire Hathaway in 1964 had ballooned to over $30 million today. That was the power of one right bet.
Kael's pulse quickened. "This could be Aurelius's Berkshire moment."
Silent Moves
He didn't tell Hana. He didn't call Leo. He didn't breathe a word.
Some opportunities couldn't be explained. If he tried, they'd only argue, hesitate, or worse—leak. This one had to be his secret.
The next days were a blur of discreet meetings with private bankers and late-night calls routed through encrypted lines. By the end of the week, the paperwork was signed.
[Loan Secured: $10,000,000]
[Personal Capital Allocated: $10,000,000]
[Total Investment in Aeterna Biocore (: $20,000,000]
No one outside of Kael and the system would ever know.
Switzerland – Where Medicine Meets Money
When Kael landed in Zurich, the air felt unnaturally clean—like it had been scrubbed by chemists. Switzerland wasn't just chocolate and watches. It was the global headquarters of biotech powerhouses: Novartis, Roche, Lonza. If a company wanted to be serious in medicine, it passed through here.
Aeterna Biocore's building gleamed on a quiet street, all glass and marble. Kael stood outside, hands in his pockets, eyes sharp.
Stock price: $72.10.
It looked harmless, like any other mid-tier biotech firm. But the system had whispered otherwise.
Kael's lips curved slightly. "They have no idea what's coming."
He didn't go inside. He didn't need to. He was already closer to their future than anyone in that building.
The Gamble
That night, in his Zurich hotel suite, Kael sat alone with a glass of whiskey. His laptop glowed with the confirmation:
Aurelius Capital now owns 20,000,000 USD in Aeterna Biocore shares.
The number stared back at him like a living thing.
Kael leaned back, exhaling slowly. "Either I just secured Aurelius's future… or I've donated forty million to Switzerland's economy."
The system shimmered faintly in his vision:
[Future Path Activated.]
Kael swirled the whiskey, watching the liquid catch the light. For the first time in a while, he felt the quiet thrill of risk—not as a burden, but as fuel.
"Step by step," he whispered.
Outside, the Swiss night stretched calm and endless. Inside, Kael Frost had just made the boldest, loneliest gamble of his life.